Inhalation Sciences in 3-year research project with 5 organizations, including purchase of new PreciseInhale system by Chiesi

STOCKHOLM, SWEDEN – July 31, 2018. Inhalation Sciences (ISAB) will collaborate in an extensive research project with RCPE (Research Center Pharmaceutical Engineering) in Graz, Austria, the Medical University of Graz, Technical University (Graz) and Italian pharmaceutical company Chiesi. Chiesi has signed a Capital Expenditure Clause for the purchase of a new PreciseInhale system to be used in the project, which has an initial value of 0.9 MSEK.

The research project is titled "Optimization of Biopharmaceutical Toolbox for Inhaled Compounds". It aims to develop new methods and processes in the production of inhaled drugs. It is being led by RCPE. The biggest industrial sponsor is one of Europe's largest and most successful pharmaceutical companies in inhaled medicines, and a long-running customer of ISAB—Chiesi (Chiesi Farmaceutici S.p.A).

Lena Heffler CEO ISAB: "We’re proud and excited that PreciseInhale has been chosen as an essential technological foundation for this new research. Chiesi’s decision to invest in a new PreciseInhale for the project, on top of the one they currently have in their labs, confirms their confidence in the system—and their powerful expertise as leading-edge innovators in inhalation. Our cooperation with all these outstanding research partners will strengthen our profile as we begin commercializing the entire range of PreciseInhale’s capabilities—from preclinical right the way through to clinical development of new inhaled therapies.”

For more information about Inhalation Sciences please contact:

Lena Heffler, CEO 
Phone: +46 (0)70 205 96 20

About Research Center Pharmaceutical Engineering (RCPE)

RCPE performs cutting-edge research in the field of process and product optimization. The main focus is on the development of new drug delivery systems and the associated production processes and their monitoring. Application-oriented research and development projects are carried out in collaboration with our industrial and scientific partners. It is our goal to strengthen our partners’ competitive edge and their economic success in the market by helping them develop novel products and production processes.

About Inhalations Sciences Sweden AB (publ)

Inhalation Sciences Sweden AB (publ) develops and commercializes world-leading instruments for research into inhalation. The company’s patented lab instrument, PreciseInhale®, enables researchers to characterize, with high precision, how aerosols and small particles impact our lungs, and so our health, when we breathe them in.

The information above was provided by Inhalation Sciences Sweden AB (publ) according to EU Market Abuse Regulations. The information was provided, through the above contact person, for publication on July 31, 2018.

About Us

Inhalation Sciences Sweden AB (publ.) develops and sells patented, highly innovative labtech equipment for inhalation research. Scientists using it can now know, with unprecedented accuracy, how particles behave in our lungs when we inhale them: whether new pollutants or life-saving drugs that power human development.


Documents & Links